Share on LinkedIn Share on Twitter Share on Facebook Luke Marshall Quoted in "Does The SPAC Have a Future in Biopharma?" Share on LinkedIn Share on Twitter Share on Facebook Life Science Sales Director, Luke Marshall from EMEA, provides his insight on the future of SPACs and how the process is still promising for biopharma companies to go public. Luke Marshall Sales Director, EMEA, DFIN To learn more, download the article below. Article Luke Marshall Quoted in "Does The SPAC Have a Future in Biopharma?" Download Related Products and Solutions Knowledge Hub Page (Insight) SPAC / De-SPAC Accelerate deals. Go public faster. Learn More Related Content Video Podcast The State of SPACs with Craig Clay, DFIN's President of Global Capital Markets